Watch again as an expert ‘treater and referrer’ panel discuss the options for CAR-T therapy in Australia, the practicalities of accessing treatment and the management implications for clinicians and patients.

Hosted by Professor Simon Harrison

Haematologist and Clinician Scientist, Sir Peter MacCallum Department of Oncology, University of Melbourne; Director of the Centre of Excellence in Cellular Immunotherapy, Peter MacCallum Cancer Centre; Chair of the Myeloma Scientific and Advisory group (MSAG), Myeloma Australia.

PANEL

Professor Joy Ho. Alan Ng Professor in Haematology, University of Sydney; Head of Department, Director of Research and Head of Haematology CAR-T Unit, Royal Prince Alfred Hospital, Sydney.

Associate Professor Kenneth Micklethwaite. Clinical Associate Professor, The University of Sydney; Haematology Staff Specialist, Westmead Hospital; Medical Director of Blood Transplant and Cell Therapies Laboratory, NSWHP – ICPMR Westmead; Research Group Leader, Centre for Cancer Research at the Westmead Institute for Medical Research.

Dr Phil Choi. Consultant Haematologist at The Canberra Hospital and Clinical Director of the National Platelet Research and Referral Centre, Canberra.

Dr Robin Gasiorowski. Consultant Haematologist, MQ Health & Concord Hospital and Senior Lecturer, Macquarie University & University of Sydney.

This event was supported by an unrestricted educational grant. It was created independently by the limbic in collaboration with the host and presenters. All studies were selected by the presenters and all views expressed are those of the host and presenters only.